Intelligence Β· Drug directory

EMA-Approved Drugs Directory

European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

Quick answer

EMA-approved drugs: NovaPharmaNews tracks 931 pharmaceutical drugs in this segment. European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

931 drugs Β· EMA approved Β· by data quality Β· Page 12 of 39

  1. alpelisib

    VIJOICE

    ORAL FDA: approved Β· EMA: approved

    L01EM03
  2. ambrisentan

    AMBRISENTAN VIATRIS Alphapharm Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved

    C02KX02
  3. amifampridine

    RUZURGI Lacuna Pharma Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    N07XX05
  4. amino acids

    MAAPLIV

    INJECTION FDA: approved Β· EMA: approved

    B05BA01
  5. anakinra

    KINERET Swedish Orphan Biovitrum Pty Ltd

    SUBCUTANEOUS FDA: approved Β· EMA: approved Β· TGA: approved

    L04AC03
  6. anidulafungin

    ECALTA

    INJECTION FDA: approved Β· EMA: approved

    J02AX06
  7. apalutamide

    ERLYAND Janssen-Cilag Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved Β· NMPA: clinical trials

    L02BB05
  8. aprocitentan

    JERAYGO

    ORAL FDA: approved Β· EMA: approved

    C02KN01
  9. artesunate

    GARSUN

    INTRAVENOUS FDA: approved Β· EMA: approved

    P01BE03
  10. asenapine

    SAPHRIS Organon Pharma Pty Ltd

    TRANSDERMAL FDA: approved Β· EMA: approved Β· TGA: approved

    N05AH05
  11. asfotase alfa

    STRENSIQ

    INJECTION FDA: approved Β· EMA: approved Β· PMDA: approved

    A16AB
  12. atezolizumab

    TECENTRIQ Hoffmann-La Roche

    INJECTION FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved Β· NMPA: clinical trials

    L01XC32
  13. atogepant

    AQUIPTA

    ORAL FDA: approved Β· EMA: approved

    N02CD07
  14. avacopan

    TAVNEOS Seqirus (Australia) Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved

    L04
  15. avanafil

    SPEDRA A.Menarini Australia Pty Limited

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    G04BE10
  16. avapritinib

    AYVAKYT

    ORAL FDA: approved Β· EMA: approved

    L01EX18
  17. avelumab

    BAVENCIO Merck KGaA, Darmstadt, Germany

    INJECTION FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved

    L01FF04
  18. aztreonam

    CAYSTON

    INJECTION FDA: approved Β· EMA: approved

    J01DF01
  19. baloxavir marboxil

    XOFLUZA

    ORAL FDA: approved Β· EMA: approved Β· PMDA: approved

  20. baricitinib

    OLUMIANT

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved Β· NMPA: clinical trials

    L04AA37
  21. basiliximab

    SIMULECT

    SINGLE-USE FDA: approved Β· EMA: approved

    L04AC02
  22. belatacept

    NULOJIX

    INJECTION FDA: approved Β· EMA: approved

    L04AA28
  23. belimumab

    BENLYSTA

    INJECTION FDA: approved Β· EMA: approved Β· PMDA: approved

    L04AG04
  24. belzutifan

    WELIREG Merck KGaA, Darmstadt, Germany

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    L01XX74

Frequently asked questions

How many ema approved drugs are listed?

931 drug profiles match this regulatory segment in our published index.

Where does approval data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.